Evidence map›Paper›PMID 37534180›Full record

ArticleiScience2023

Cannabinoid receptor type 1 (CB

Gergő Szanda, Tony Jourdan, Éva Wisniewski, Resat Cinar, Grzegorz Godlewski, Anikó Rajki, Jie Liu, Lee Chedester, Bence Szalai, András Dávid Tóth and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 5 countries.

Gergő SzandaDepartment of Physiology, Semmelweis University Medical School, 1094 Budapest, Hungary.
Tony JourdanINSERM Center Lipids, Nutrition, Cancer LNC U1231, 21000 Dijon, France.
Éva WisniewskiDepartment of Physiology, Semmelweis University Medical School, 1094 Budapest, Hungary.
Resat CinarLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
Grzegorz GodlewskiLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
Anikó RajkiDepartment of Physiology, Semmelweis University Medical School, 1094 Budapest, Hungary.
Jie LiuLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
Lee ChedesterLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
Bence SzalaiDepartment of Physiology, Semmelweis University Medical School, 1094 Budapest, Hungary.
András Dávid TóthDepartment of Physiology, Semmelweis University Medical School, 1094 Budapest, Hungary.
Eszter Soltész-KatonaDepartment of Physiology, Semmelweis University Medical School, 1094 Budapest, Hungary.
László HunyadyDepartment of Physiology, Semmelweis University Medical School, 1094 Budapest, Hungary.
Asuka InoueGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
Viktória Bea HorváthDepartment of Physiology, Semmelweis University Medical School, 1094 Budapest, Hungary.
András SpätDepartment of Physiology, Semmelweis University Medical School, 1094 Budapest, Hungary.
Joseph TamObesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
George KunosLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
Semmelweis University · HUNational Institutes of Health · USHungarian Research NetworkHebrew University of Jerusalem · ILHungarian Academy of Sciences · HUInserm · FRNational Institute on Alcohol Abuse and Alcoholism · USTohoku University · JP

Funding

Fibroproliferative mechanisms in organ fibrosisZIAAA000355 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI CINAR, RESAT · 2021 to 2025
$6.6M
6 · The paper itself

Abstract

Molecular interactions between anorexigenic leptin and orexigenic endocannabinoids, although of great metabolic significance, are not well understood. We report here that hypothalamic STAT3 signaling in mice, initiated by physiological elevations of leptin, is diminished by agonists of the cannabinoid receptor 1 (CB

Indexed as

Cell biologyMolecular biology

Identifiers

PMID37534180
PMCPMC10392084
OpenAlexW4381951030

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.